APLT Investors Class Action Reminder: Important Information from Kessler Topaz Meltzer & Check
A class action lawsuit was recently filed in the United States District Court for the Southern District of New York against Applied Therapeutics, Inc. This legal action alleges violations of federal securities laws and seeks to represent shareholders who purchased the company’s stock between November 20, 2019, and January 13, 2021.
The lawsuit claims that Applied Therapeutics made false and misleading statements regarding the company’s business operations and prospects. Specifically, the complaint alleges that the company failed to disclose crucial information concerning the results of its clinical trials for a drug candidate, and that as a result, the stock price was artificially inflated.
Investors who suffered financial losses as a result of purchasing Applied Therapeutics stock during the specified time period may be eligible to participate in the class action lawsuit. To learn more about the case and how to become involved, shareholders are encouraged to contact the law firm representing the plaintiffs.
It’s important for investors to stay informed about the companies in which they choose to invest, and to be aware of any legal actions that may impact the value of their holdings. Keeping abreast of developments like class action lawsuits can help investors make informed decisions and protect their financial interests.
